Correlation Between Synmosa Biopharma and Taiwan Glass

Can any of the company-specific risk be diversified away by investing in both Synmosa Biopharma and Taiwan Glass at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synmosa Biopharma and Taiwan Glass into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Synmosa Biopharma and Taiwan Glass Ind, you can compare the effects of market volatilities on Synmosa Biopharma and Taiwan Glass and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synmosa Biopharma with a short position of Taiwan Glass. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synmosa Biopharma and Taiwan Glass.

Diversification Opportunities for Synmosa Biopharma and Taiwan Glass

-0.62

Correlation Coefficient

Synmosa Biopharma  Taiwan Glass

Excellent diversification

The 3 months correlation between Synmosa and Taiwan is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Synmosa Biopharma and Taiwan Glass Ind in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taiwan Glass Ind and Synmosa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synmosa Biopharma are associated (or correlated) with Taiwan Glass. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taiwan Glass Ind has no effect on the direction of Synmosa Biopharma i.e., Synmosa Biopharma and Taiwan Glass go up and down completely randomly.

Pair Corralation between Synmosa Biopharma and Taiwan Glass

Assuming the 90 days trading horizon Synmosa Biopharma is expected to under-perform the Taiwan Glass. But the stock apears to be less risky and, when comparing its historical volatility, Synmosa Biopharma is 3.0 times less risky than Taiwan Glass. The stock trades about -0.38 of its potential returns per unit of risk. The Taiwan Glass Ind is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,825  in Taiwan Glass Ind on September 14, 2024 and sell it today you would earn a total of  65.00  from holding Taiwan Glass Ind or generate 3.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Synmosa Biopharma  vs.  Taiwan Glass Ind

Synmosa Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Taiwan Glass Ind

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Taiwan Glass Ind are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Taiwan Glass showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Synmosa Biopharma and Taiwan Glass

The main advantage of trading using opposite Synmosa Biopharma and Taiwan Glass positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synmosa Biopharma position performs unexpectedly, Taiwan Glass can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taiwan Glass will offset losses from the drop in Taiwan Glass' long position.

The idea behind Synmosa Biopharma and Taiwan Glass Ind pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.